Published in Respiration on December 21, 2009
Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions. PLoS One (2013) 0.76
Endocan and the respiratory system: a review. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol (2013) 2.38
Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am J Respir Crit Care Med (2009) 2.10
Foxp3 expression in human cancer cells. J Transl Med (2008) 1.94
Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest (2007) 1.91
Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure. Int J Cardiol (2012) 1.68
The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD (2011) 1.61
Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates? Chest (2005) 1.59
Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. Nephrol Dial Transplant (2007) 1.46
The role of leptin in the respiratory system: an overview. Respir Res (2010) 1.30
Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res (2006) 1.22
Prevalence of chronic diseases and morbidity in primary health care in central Greece: an epidemiological study. BMC Health Serv Res (2010) 1.15
COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J (2010) 1.10
Underdiagnosis of respiratory diseases during an economic downturn and the need for spirometry as a screening test. J Bras Pneumol (2013) 1.09
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer Biol Ther (2007) 1.06
Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol (2003) 1.06
Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest (2011) 1.04
Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med (2009) 1.03
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respir Med (2009) 1.03
Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol (2005) 1.03
Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med (2007) 1.01
VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer (2008) 0.99
Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem (2008) 0.98
Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med (2009) 0.97
Prevalence of sleep-related symptoms in a primary care population - their relation to asthma and COPD. Prim Care Respir J (2007) 0.96
Diabetes mellitus and lung function. Med Princ Pract (2003) 0.96
Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif (2005) 0.95
Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Clin Dev Immunol (2010) 0.94
Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control. Respir Med (2010) 0.94
Depression and pulmonary function in outpatients with asthma. Respir Med (2004) 0.94
Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med (2008) 0.94
Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer (2004) 0.94
Global assessment of the COPD patient: time to look beyond FEV1? Respir Med (2009) 0.93
Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem (2009) 0.92
Noninvasive ventilation in chronic respiratory failure: effects on quality of life. Respiration (2010) 0.92
Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J (2013) 0.91
Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD (2011) 0.91
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine (2013) 0.90
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J (2012) 0.90
Statins and outcome after hospitalization for COPD exacerbation: a prospective study. Pulm Pharmacol Ther (2011) 0.89
Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.88
A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion. J Clin Endocrinol Metab (2006) 0.88
Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respir Med (2005) 0.88
Oxidative stress in patients with COPD. Curr Drug Targets (2011) 0.88
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy. Cancer Biol Ther (2007) 0.88
Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath (2012) 0.88
Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions. Chest (2005) 0.88
Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration (2006) 0.88
Effects of hypoxia on diaphragmatic fatigue in highly trained athletes. J Physiol (2007) 0.88
Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea. Pediatr Pulmonol (2010) 0.87
Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest (2009) 0.87
Prognostic value of C-reactive protein in parapneumonic effusions. Respirology (2012) 0.86
Vibration response imaging: evaluation of rater agreement in healthy subjects and subjects with pneumonia. BMC Med Imaging (2010) 0.86
Clinical significance of serum adipokines levels in lung cancer. Med Oncol (2013) 0.85
Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers. Respir Res (2011) 0.85
Effects of exercise-induced arterial hypoxaemia and work rate on diaphragmatic fatigue in highly trained endurance athletes. J Physiol (2006) 0.85
Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker. Acta Haematol (2012) 0.85
Respiratory tract mortality in cement workers: a proportionate mortality study. BMC Pulm Med (2012) 0.85
Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Heart Lung (2008) 0.85
Mitochondrial genetic background plays a role in increasing risk to asthma. Mol Biol Rep (2011) 0.84
Chronic obstructive pulmonary disease exacerbation frequency and severity. Int J Chron Obstruct Pulmon Dis (2013) 0.84
Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals. Clin Immunol (2008) 0.84
Overnight changes in the cerebral vascular response to isocapnic hypoxia and hypercapnia in healthy humans: protection against stroke. Stroke (2005) 0.84
Secondhand smoke exposure induces acutely airway acidification and oxidative stress. Respir Med (2012) 0.84
Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas. Lung Cancer (2008) 0.84
Increased levels of osteopontin in sputum supernatant of smoking asthmatics. Cytokine (2012) 0.84
Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis. Respir Med (2011) 0.83
Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res (2013) 0.83
Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD. Prim Care Respir J (2013) 0.83
Anti-survivin antibody responses in lung cancer. Cancer Lett (2009) 0.83